Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results | Business Wire
Puma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial Results | Business Wire
Insider Transaction Reveals Sale of Puma Biotechnology Shares by Board Member - Best Stocks
Puma Biotech (PBYI) Stock up as Q2 Earnings & Sales Beat
Puma Biotechnology Surging
Puma Biotechnology Inc (PBYI) Stock News | Stock Titan
PBYI - Puma Biotechnology, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS)
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q4 2023 Earnings Call Transcript - Insider Monkey
Is Puma Biotechnology (PBYI) Stock a Solid Choice Right Now?
Puma Biotech's Stock Soars to New High, but Technical Analysis Signals Caution
Puma Biotechnology
Earnings call: Puma Biotechnology reports mixed Q4 results, eyes future growth By Investing.com
Puma Biotechnology
PBYI Stock Price and Chart — NASDAQ:PBYI — TradingView
Puma Biotechnology | $PBYI Stock | Shares Climb Up as Company Announced FDA Approval for NERLYNX - Warrior Trading News
A Top Puma Bio Exec Resigns Ahead of FDA Panel, Analysts Defend With Conflicting Stories - TheStreet
Puma Biotechnology (PBYI) Q4 Earnings & Revenues Lag Estimates - March 1, 2024 - Zacks.com
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
Puma Biotechnology Inc.: Stock Market News and Information
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Investors in Puma Biotechnology (NASDAQ:PBYI) from five years ago are still down 80%, even after 11% gain this past week
Puma Biotechnology: Profitable, Troubled, But Worth A Good Look (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Wealth DFM
